What are Hypertrophic Scar?
Hypertrophic Scars are raised, red, rigid, inflexible cell-like, and cosmetic problems precipitated due to multiple underlying dermal injuries such as burn, surgery, and trauma during which aberrant wound healing with more pathological deposition of the extracellular matrix than degradation leads to their spawning.
How Hypertrophic Scar affected population?
Hypertrophic Scar Epidemiology –
- Females and males have equal risk of developing Hypertrophic Scar.
- Adolescents and pregnant women may have a greater probability of forming Hypertrophic Scar.
- Incidence rates of Hypertrophic Scar have been reported as high as 91% following extensive trauma, such as a deep burn injury, suggesting a role for the extent of trauma in their development.
Hypertrophic Scar Market Outlook
According to DelveInsight, Hypertrophic Scar market in 7MM is expected to change in the study period 2017-2030. The key driver for the surge in Hypertrophic Scar market size is the rise in number of incident/prevalent cases.
Neodyne Biosciences’ Embrace Advanced Scar Therapy System has been approved by the FDA top treat HTSs. It delivers mechano-modulation therapy to the injury site and surrounding tissues. The device includes a simple disposable applicator that transfers a predetermined level of strain to a single use adhesive silicone sheet, which is then adhered over the closed scar. This unique mechanism of action provides a uniform compressive strain, or stress-shield around a closed scar, which can minimize collagen proliferation and formation of scar tissue. The Embrace device was cleared by the FDA in September 2011 and is the only FDA-Cleared scar therapy system designed to relieve tension around incisions, general cuts and lacerations to prevent the formation of new, visible, raised scars before they start.
The Hypertrophic Scar market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Hypertrophic Scar market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
To know more, request sample pages @Hypertrophic Scar Market Landscape
Which are the leading companies in Hypertrophic Scar market?
The pipeline of Hypertrophic scars is quiet weak with few potential key players, such as Henry Ford Health System/ Gladerma, Phio Pharmaceuticals and others. The dynamics of HTS market is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise of efficient treatment options. The launch of emerging therapies is expected during the forecast period of 2020–2030.
Request sample pages for more information on Hypertrophic Scar Market Report